• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肠系膜缺血引起的肠道菌群失调在血管重建后得到缓解。

Chronic mesenteric ischemia-induced intestinal dysbiosis resolved after revascularization.

作者信息

Munley Jennifer A, Nagpal Ravinder, Hanson Nancy C, Mirzaie Amin, Laquian Liza, Mohr Alicia M, Efron Philip A, Arnaoutakis Dean J, Cooper Michol A

机构信息

Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, University of Florida College of Medicine, Gainesville, FL.

Department of Nutrition and Integrative Physiology, Florida State University College of Health and Human Sciences, Tallahassee, FL.

出版信息

J Vasc Surg Cases Innov Tech. 2022 Dec 23;9(2):101084. doi: 10.1016/j.jvscit.2022.101084. eCollection 2023 Jun.

DOI:10.1016/j.jvscit.2022.101084
PMID:36970136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10033993/
Abstract

OBJECTIVE

Chronic mesenteric ischemia (CMI) is a debilitating condition arising from intestinal malperfusion from mesenteric artery stenosis or occlusion. Mesenteric revascularization has been the standard of care but can result in substantial morbidity and mortality. Most of the perioperative morbidity has been secondary to postoperative multiple organ dysfunction, potentially from ischemia-reperfusion injury. The intestinal microbiome is a dense community of microorganisms in the gastrointestinal tract that help regulate pathways ranging from nutritional metabolism to the immune response. We hypothesized that patients with CMI will have microbiome perturbations that contribute to this inflammatory response and could potentially normalize in the postoperative period.

METHODS

We performed a prospective study of patients with CMI who had undergone mesenteric bypass and/or stenting from 2019 to 2020. Stool samples were collected at three time points: preoperatively at the clinic, perioperatively within 14 days after surgery, and postoperatively at the clinic at >30 days after revascularization. Stool samples from healthy controls were used for comparison. The microbiome was measured using 16S rRNA sequencing on an Illumina-MiSeq sequence platform and analyzed using the QIIME2 (quantitative insights into microbial ecology 2)-DADA2 bioinformatics pipeline with the Silva database. Beta-diversity was analyzed using a principal coordinates analysis and permutational analysis of variance. Alpha-diversity (microbial richness and evenness) was compared using the nonparametric Mann-Whitney test. Microbial taxa unique to CMI patients vs controls were identified using linear discriminatory analysis effect size analysis.  < .05 was considered statistically significant.

RESULTS

Eight patients with CMI had undergone mesenteric revascularization (25% men; average age, 71 years). Nine healthy controls were also analyzed (78% men; average age, 55 years). Bacterial alpha-diversity (number of operational taxonomic units) was dramatically reduced preoperatively compared with that of the controls ( = .03). However, revascularization partially restored the species richness and evenness in the perioperative and postoperative phases. Beta-diversity was only different between the perioperative and postoperative groups ( = .03). Further analyses revealed increased abundance of and taxa preoperatively and perioperatively compared with the controls, which was reduced during the postoperative period.

CONCLUSIONS

The results from the present study have shown that patients with CMI have intestinal dysbiosis that resolves after revascularization. The intestinal dysbiosis is characterized by the loss of alpha-diversity, which is restored perioperatively and maintained postoperatively. This microbiome restoration demonstrates the importance of intestinal perfusion to sustain gut homeostasis and suggests that microbiome modulation could be a possible intervention to ameliorate acute and subacute postoperative outcomes in these patients.

摘要

目的

慢性肠系膜缺血(CMI)是一种因肠系膜动脉狭窄或闭塞导致肠道灌注不良而引起的使人衰弱的病症。肠系膜血管重建一直是标准的治疗方法,但可能导致较高的发病率和死亡率。围手术期的大多数发病率继发于术后多器官功能障碍,可能源于缺血再灌注损伤。肠道微生物群是胃肠道中密集的微生物群落,有助于调节从营养代谢到免疫反应等多种途径。我们假设,CMI患者会出现微生物群紊乱,这会导致这种炎症反应,并且在术后可能恢复正常。

方法

我们对2019年至2020年接受肠系膜旁路手术和/或支架置入术的CMI患者进行了一项前瞻性研究。在三个时间点收集粪便样本:术前在诊所、围手术期在术后14天内、术后在血管重建术后>30天在诊所。使用来自健康对照者的粪便样本进行比较。使用Illumina-MiSeq序列平台上的16S rRNA测序测量微生物群,并使用带有Silva数据库的QIIME2(微生物生态学定量见解2)-DADA2生物信息学管道进行分析。使用主坐标分析和置换方差分析来分析β多样性。使用非参数曼-惠特尼检验比较α多样性(微生物丰富度和均匀度)。使用线性判别分析效应大小分析来确定CMI患者与对照者独特的微生物分类群。P <.05被认为具有统计学意义。

结果

8例CMI患者接受了肠系膜血管重建(25%为男性;平均年龄71岁)。还分析了9名健康对照者(78%为男性;平均年龄55岁)。与对照组相比,术前细菌α多样性(可操作分类单元数量)显著降低(P =.03)。然而,血管重建在围手术期和术后阶段部分恢复了物种丰富度和均匀度。β多样性仅在围手术期和术后组之间存在差异(P =.03)。进一步分析显示,与对照组相比,术前和围手术期某些分类群的丰度增加,而在术后阶段减少。

结论

本研究结果表明,CMI患者存在肠道生态失调,血管重建后可得到缓解。肠道生态失调的特征是α多样性丧失,在围手术期恢复并在术后维持。这种微生物群的恢复证明了肠道灌注对维持肠道内环境稳定的重要性,并表明微生物群调节可能是改善这些患者急性和亚急性术后结局的一种可能干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/effb/10033993/e98998956967/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/effb/10033993/43f07d47f51d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/effb/10033993/8e37e42907d4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/effb/10033993/e98998956967/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/effb/10033993/43f07d47f51d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/effb/10033993/8e37e42907d4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/effb/10033993/e98998956967/gr3.jpg

相似文献

1
Chronic mesenteric ischemia-induced intestinal dysbiosis resolved after revascularization.慢性肠系膜缺血引起的肠道菌群失调在血管重建后得到缓解。
J Vasc Surg Cases Innov Tech. 2022 Dec 23;9(2):101084. doi: 10.1016/j.jvscit.2022.101084. eCollection 2023 Jun.
2
Effect of ischemia-reperfusion on outcomes after open mesenteric bypass for chronic mesenteric ischemia.缺血再灌注对慢性肠系膜缺血开放肠系膜旁路术后结局的影响。
J Vasc Surg. 2021 Oct;74(4):1301-1308.e1. doi: 10.1016/j.jvs.2021.03.039. Epub 2021 Apr 19.
3
Taxonomic annotation of 16S rRNA sequences of pig intestinal samples using MG-RAST and QIIME2 generated different microbiota compositions.使用 MG-RAST 和 QIIME2 对猪肠道样本的 16S rRNA 序列进行分类注释产生了不同的微生物群落组成。
J Microbiol Methods. 2021 Jul;186:106235. doi: 10.1016/j.mimet.2021.106235. Epub 2021 May 8.
4
Mesenteric stenting for chronic mesenteric ischemia.慢性肠系膜缺血的肠系膜支架置入术。
J Vasc Surg. 2005 Aug;42(2):268-74. doi: 10.1016/j.jvs.2005.03.054.
5
Short-term outcomes for open revascularization of chronic mesenteric ischemia.慢性肠系膜缺血开放血管重建术的短期疗效
Ann Vasc Surg. 2012 May;26(4):447-53. doi: 10.1016/j.avsg.2011.11.006. Epub 2012 Jan 27.
6
Whole blood resuscitation restores intestinal perfusion and influences gut microbiome diversity.全血复苏恢复肠道灌注并影响肠道微生物组多样性。
J Trauma Acute Care Surg. 2021 Dec 1;91(6):1002-1009. doi: 10.1097/TA.0000000000003381.
7
Revascularization of the superior mesenteric artery alone for treatment of chronic mesenteric ischemia.单纯肠系膜上动脉血运重建术治疗慢性肠系膜缺血。
Wien Klin Wochenschr. 2016 Feb;128(3-4):109-13. doi: 10.1007/s00508-015-0897-1. Epub 2015 Dec 9.
8
Covered stents versus Bare-metal stents in chronic atherosclerotic Gastrointestinal Ischemia (CoBaGI): study protocol for a randomized controlled trial.覆膜支架与裸金属支架治疗慢性动脉粥样硬化性胃肠道缺血(CoBaGI)的随机对照试验研究方案。
Trials. 2019 Aug 20;20(1):519. doi: 10.1186/s13063-019-3609-8.
9
Impact of Body Mass Index on Outcomes after Mesenteric Revascularization for Chronic Mesenteric Ischemia.体重指数对慢性肠系膜缺血行肠系膜血管重建术后结局的影响。
Ann Vasc Surg. 2018 Apr;48:159-165. doi: 10.1016/j.avsg.2017.09.026. Epub 2017 Dec 5.
10
A comparison of sequencing platforms and bioinformatics pipelines for compositional analysis of the gut microbiome.用于肠道微生物组组成分析的测序平台和生物信息学管道的比较。
BMC Microbiol. 2017 Sep 13;17(1):194. doi: 10.1186/s12866-017-1101-8.

引用本文的文献

1
Oxygenation and intestinal perfusion and its association with perturbations of the early life gut microbiota composition of children with congenital heart disease.氧合与肠道灌注及其与先天性心脏病患儿早期生命肠道微生物群组成扰动的关联。
Front Microbiol. 2025 Jan 15;15:1468842. doi: 10.3389/fmicb.2024.1468842. eCollection 2024.
2
Early Enteral Nutrition May Improve Survival in Patients With Cardiogenic Shock.早期肠内营养可能改善心源性休克患者的生存率。
Emerg Med Int. 2025 Jan 6;2025:1465194. doi: 10.1155/emmi/1465194. eCollection 2025.
3
Nonselective beta blockade enhances gut microbiome diversity in a rodent model of trauma, hemorrhage, and chronic stress.

本文引用的文献

1
Microbiota succession throughout life from the cradle to the grave.从摇篮到坟墓,贯穿一生的微生物群演替。
Nat Rev Microbiol. 2022 Dec;20(12):707-720. doi: 10.1038/s41579-022-00768-z. Epub 2022 Jul 29.
2
Association of Gut Microbiota With Intestinal Ischemia/Reperfusion Injury.肠道微生物群与肠道缺血/再灌注损伤的关系。
Front Cell Infect Microbiol. 2022 Jul 12;12:962782. doi: 10.3389/fcimb.2022.962782. eCollection 2022.
3
Lactobacillus murinus alleviate intestinal ischemia/reperfusion injury through promoting the release of interleukin-10 from M2 macrophages via Toll-like receptor 2 signaling.
在创伤、出血和慢性应激的啮齿动物模型中,非选择性β受体阻滞剂可增强肠道微生物群的多样性。
J Trauma Acute Care Surg. 2025 Feb 1;98(2):309-318. doi: 10.1097/TA.0000000000004461. Epub 2024 Nov 13.
4
POSTINJURY PNEUMONIA INDUCES A UNIQUE BLOOD MICROBIOME SIGNATURE.创伤性肺炎会导致独特的血液微生物组特征。
Shock. 2024 Dec 1;62(6):762-771. doi: 10.1097/SHK.0000000000002428. Epub 2024 Aug 8.
5
Revascularization Strategies for Acute and Chronic Mesenteric Ischemia: A Narrative Review.急性和慢性肠系膜缺血的血运重建策略:一篇叙述性综述
J Clin Med. 2024 Feb 21;13(5):1217. doi: 10.3390/jcm13051217.
6
Sex-specific intestinal dysbiosis persists after multicompartmental injury.性别特异性肠道失调在多 compartment 损伤后仍然存在。
Surgery. 2023 Dec;174(6):1453-1462. doi: 10.1016/j.surg.2023.08.023. Epub 2023 Oct 11.
鼠李糖乳杆菌通过 Toll 样受体 2 信号通路促进 M2 巨噬细胞释放白细胞介素-10 缓解肠道缺血再灌注损伤。
Microbiome. 2022 Mar 3;10(1):38. doi: 10.1186/s40168-022-01227-w.
4
Preoperative fasting confers protection against intestinal ischaemia/reperfusion injury by modulating gut microbiota and their metabolites in a mouse model.术前禁食通过调节肠道微生物群及其代谢物在小鼠模型中预防肠道缺血/再灌注损伤。
Br J Anaesth. 2022 Mar;128(3):501-512. doi: 10.1016/j.bja.2021.11.025. Epub 2021 Dec 18.
5
The Impact of a Mediterranean Diet on the Gut Microbiome in Healthy Human Subjects: A Pilot Study.地中海饮食对健康人体肠道微生物组的影响:一项初步研究。
Digestion. 2022;103(2):133-140. doi: 10.1159/000519445. Epub 2021 Nov 8.
6
Gut Microbial Metabolite Pravastatin Attenuates Intestinal Ischemia/Reperfusion Injury Through Promoting IL-13 Release From Type II Innate Lymphoid Cells IL-33/ST2 Signaling.肠道微生物代谢产物普伐他汀通过促进 II 型先天淋巴细胞释放白细胞介素 13 来减轻肠缺血/再灌注损伤:IL-33/ST2 信号通路。
Front Immunol. 2021 Sep 28;12:704836. doi: 10.3389/fimmu.2021.704836. eCollection 2021.
7
The Gut Microbiome and Sex Hormone-Related Diseases.肠道微生物群与性激素相关疾病
Front Microbiol. 2021 Sep 28;12:711137. doi: 10.3389/fmicb.2021.711137. eCollection 2021.
8
Conversion of dietary inositol into propionate and acetate by commensal Anaerostipes associates with host health.共生拟杆菌将膳食肌醇转化为丙酸和乙酸与宿主健康有关。
Nat Commun. 2021 Aug 10;12(1):4798. doi: 10.1038/s41467-021-25081-w.
9
Antioxidant-Based Therapy Reduces Early-Stage Intestinal Ischemia-Reperfusion Injury in Rats.基于抗氧化剂的疗法可减轻大鼠早期肠道缺血再灌注损伤。
Antioxidants (Basel). 2021 May 27;10(6):853. doi: 10.3390/antiox10060853.
10
Effect of ischemia-reperfusion on outcomes after open mesenteric bypass for chronic mesenteric ischemia.缺血再灌注对慢性肠系膜缺血开放肠系膜旁路术后结局的影响。
J Vasc Surg. 2021 Oct;74(4):1301-1308.e1. doi: 10.1016/j.jvs.2021.03.039. Epub 2021 Apr 19.